Skip to main content
Clinical Trials/TCTR20240329002
TCTR20240329002
Not yet recruiting
Phase 3

Effects of Holistic Program for Reducing Fatigue among Sepsis Survivors

/A0 sites68 target enrollmentMarch 29, 2024

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Sepsis Survivors
Sponsor
/A
Enrollment
68
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 29, 2024
End Date
July 31, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
/A

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient aged 18 \- 85 years who treated sepsis for more than 48 hours with normal vital signs and no signs and symptoms associated with SIRS criteria and no symptoms and signs of multiple organ dysfunction according to SOFA or qSOFA criteria.
  • 2\. The patient has no physical abnormalities. (with bone injuries and arthritis, osteoarthritis, gout, etc.)
  • 3\. Patient aged 60 years and over after taking the Mini Cog test and receiving a score greater than or equal to 3 again.
  • 4\. Patient who has experience symptoms of fatigue, evaluated by using the Piper Fatigue Scale\-12 questionnaire, moderate or higher or with a PFS\-12 score greater than equal to 4 points.
  • 5\. Able to communicate by speaking, reading, and writing Thai.
  • 6\. The patient or caregiver has a smart phone. and can use the LINE application.

Exclusion Criteria

  • 1\. The patient has co\-morbidities that cause fatigue easily which does not occur after sepsis, such as cancer undergoing chemotherapy or radiotherapy, HIV patients with a CD4 level lower than 350 cubic millimeters, chronic obstructive pulmonary disease, asthma, kidney failure stage 4 or higher, liver disease with Child Pugh Score C, anemia with hemoglobin less than 7 g/dl, malnutrition with serum albumin less than 2, heart failure. Have had a history of being infected with coronavirus 19, which was accompanied by fatigue.
  • 2\. Patients with neurological and brain disorders, such as spinal cord injuries, or had surgery related to the nervous system and brain.
  • 3\. Patients diagnosed with psychiatric disorders such as schizophrenia, bipolar disorder or severe depression.
  • 4\. Terminally ill patients or bedridden patients

Outcomes

Primary Outcomes

Not specified

Similar Trials